Article Sidebar
Published:
Apr 15, 2026Keywords:
Article Details
http://www.sajp.org.za/index.php/sajp/pages/view/policies#part_4
Copyright
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publishing rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose.
AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
Read more here: http://creativecommons.org/licenses/by/4.0/.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Main Article Content
A case report: Neuroimaging in an atypical presentation of Parkinson’s disease
Abstract
Introduction: Parkinson’s disease (PD) is the second leading neurodegenerative disorder in the world. The diagnosis of idiopathic Parkinson’s disease (IPD) is mainly through clinical presentation of motor and non-motor symptoms. Motor symptoms include tremor,
bradykinesia and rigidity. Atypical parkinsonism may pose a challenge in diagnosing IPD. Functional neuroimaging can assist in diagnosing IPD and in differentiating it from atypical parkinsonism due to other neurodegenerative aetiologies.
Patient presentation: We present a case report of a patient with atypical parkinsonism and mild neurocognitive disorder.
Management and outcome: Neuroimaging revealed IPD, distinguishing it from other causes of neurocognitive disorders. The patient received multidisciplinary team (MDT) input and appropriate medication, including a fixed combination of carbidopa and levodopa,
rivastigmine, venlafaxine and quetiapine with improvement of his symptomatology.
Conclusion: Neuroimaging assisted in establishing the diagnosis and guiding treatment.
Contribution: Although evidence and studies are needed for definitive use in clinical practice, there is supportive evidence to suggest the diagnostic utility of these modalities in parkinsonian syndromes.
